EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Validation and Establishment of the SARS-CoV-2 Lentivirus Surrogate Neutralization Assay as a Prescreening Tool for the Plaque Reduction Neutralization Test

John Merluza, Johnny Ung, Kai Makowski, Alyssia Robinson, Kathy Manguiat, Nicole Mueller, Jonathan Audet, Julie Chih-Yu Chen, James E Strong iD, Heidi Wood, Alexander Bello iD

Microbiology Spectrum · 2023

DOI: 10.1128/spectrum.03789-22 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiology Spectrum, 2023. Verfasst von John Merluza und 10 weiteren Autor:innen. Beteiligte Einrichtung: Public Health Agency of Canada, National Microbiology Laboratory, Winnipeg, Manitoba, Canada. Hauptthemen laut MEDLINE: SARS-CoV-2, COVID-19. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neutralization studies play an important role in providing guidance and justification for vaccine administration and helping prevent the spread of diseases. The neutralization data generated in our laboratory have been included in the decision-making process of the National Advisory Committee on Immunization (NACI) in Canada.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SARS-CoV-2COVID-19HumansNeutralization TestsAntibodies, ViralLentivirusAntibodies, Neutralizing

Stichwörter der Autor:innen

SARS-CoV-2 lentivirus surrogate neutralization assayplaque reduction neutralization testvalidation

Substanzen

Antibodies, ViralAntibodies, Neutralizing

Autor:innen und Institutionen

  • Public Health Agency of Canada, National Microbiology Laboratory, Winnipeg, Manitoba, Canada.
  • Department of Biochemistry and Medical Genetics, University of Manitoba, Winnipeg, Manitoba, Canada.
  • Department of Pediatrics & Child Health, University of Manitoba, Winnipeg, Manitoba, Canada.
  • Department of Medical Microbiology & Infectious Diseases, University of Manitoba, Winnipeg, Manitoba, Canada.

ORCID-Profile: James E Strong, Alexander Bello

Zitieren

APA

Merluza, J., Ung, J., Makowski, K., Robinson, A., Manguiat, K., Mueller, N., Audet, J., Chen, J. C., Strong, J. E., Wood, H., & Bello, A. (2023). Validation and Establishment of the SARS-CoV-2 Lentivirus Surrogate Neutralization Assay as a Prescreening Tool for the Plaque Reduction Neutralization Test. Microbiology Spectrum. https://doi.org/10.1128/spectrum.03789-22

Vancouver

Merluza J, Ung J, Makowski K, Robinson A, Manguiat K, Mueller N, et al. Validation and Establishment of the SARS-CoV-2 Lentivirus Surrogate Neutralization Assay as a Prescreening Tool for the Plaque Reduction Neutralization Test. Microbiology Spectrum. 2023. doi:10.1128/spectrum.03789-22

BibTeX
@article{Merluza2023,
  author = {Merluza, John and Ung, Johnny and Makowski, Kai and Robinson, Alyssia and Manguiat, Kathy and Mueller, Nicole and Audet, Jonathan and Chen, Julie Chih-Yu and Strong, James E and Wood, Heidi and Bello, Alexander},
  title = {Validation and Establishment of the SARS-CoV-2 Lentivirus Surrogate Neutralization Assay as a Prescreening Tool for the Plaque Reduction Neutralization Test},
  journal = {Microbiology Spectrum},
  year = {2023},
  doi = {10.1128/spectrum.03789-22}
}
Kostenlos starten →